These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 241307)

  • 1. Behavioral Effects of Reducing the Daily Frequency of Phenothiazine Administration.
    Callahan EJ; Alevizos PN; Teigen JR; Newman H; Campbell MD
    Arch Gen Psychiatry; 1975 Oct; 32(10):1285-90. PubMed ID: 241307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of phenothiazine withdrawal on proverb interpretation by chronic schizophrenics.
    Chapman LJ; Cameron R; Cocke JG; Pritchett T
    J Abnorm Psychol; 1975 Feb; 84(1):24-9. PubMed ID: 234133
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of physostigmine in phenothiazine resistant chronic schizophrenic patients: preliminary observations.
    Rosenthal R; Bigelow LB
    Compr Psychiatry; 1973; 14(6):489-94. PubMed ID: 4148747
    [No Abstract]   [Full Text] [Related]  

  • 4. The Dose Reduction in Schizophrenia (DORIS) Study: a final report.
    Hirschowitz J; Hitzemann R; Piscani K; Burr G; Frecska E; Culliton D; Mann M; Curtis C
    Schizophr Res; 1997 Jan; 23(1):31-43. PubMed ID: 9050126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of drugs in schizophrenia.
    Leff JP
    Br J Clin Pharmacol; 1976 Feb; 3(1 Suppl 1):75-8. PubMed ID: 9960
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of chronic administration of centrally acting compounds on chloramphenicol metabolism in schizophrenic patients.
    Watanabe A
    Pharmacology; 1974; 11(4):253-6. PubMed ID: 4156595
    [No Abstract]   [Full Text] [Related]  

  • 7. Do chronic schizophrenics in hospital need more than one neuroleptic drug?
    Rao VA; Coppen A
    Br J Psychiatry; 1979 Feb; 134():222-3, 4. PubMed ID: 34458
    [No Abstract]   [Full Text] [Related]  

  • 8. [Administration of once-daily extended release quetiapine in schizophrenic disorders].
    Bartkó G
    Neuropsychopharmacol Hung; 2007 Dec; 9(4):189-95. PubMed ID: 18510263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group.
    Small JG; Hirsch SR; Arvanitis LA; Miller BG; Link CG
    Arch Gen Psychiatry; 1997 Jun; 54(6):549-57. PubMed ID: 9193196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of pharmacotherapy with classic neuroleptics: phenothiazine derivatives in schizophrenia].
    Kleszczewska E; Hejza J
    Pol Merkur Lekarski; 2003 Feb; 14(80):136-8. PubMed ID: 12728674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Auditory signal detection in paranoid and nonparanoid schizophrenics.
    Rappaport M; Hopkins HK; Hall K
    Arch Gen Psychiatry; 1972 Dec; 27(6):747-52. PubMed ID: 4404700
    [No Abstract]   [Full Text] [Related]  

  • 12. Antipsychotic medication in the treatment of schizophrenia.
    Kane JM
    Isr J Psychiatry Relat Sci; 1995; 32(1):30-7. PubMed ID: 7542642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of phenothiazine treatment on the physical properties of platelet membranes from psychiatric patients.
    Zubenko GS; Cohen BM
    Biol Psychiatry; 1985 Apr; 20(4):384-96. PubMed ID: 2858228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship of the brief psychiatric rating scale to neuropsychological deficits in phenothiazine-treated schizophrenics.
    Golden CJ; Carpenter B; Wilkening G; Ruedrich S; Chu CC; Graber B
    Psychopharmacol Bull; 1983; 19(3):513-7. PubMed ID: 6138799
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy and safety of once-daily quetiapine extended release in patients with schizophrenia switched from other antipsychotics: an open-label study in Chinese population.
    Pan PY; Lee MS; Yeh CB
    BMC Psychiatry; 2015 Jan; 15():1. PubMed ID: 25609320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical observations with aripiprazole in schizophrenia].
    Gaszner P
    Neuropsychopharmacol Hung; 2006 Mar; 8(1):29-32. PubMed ID: 16841563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dosage piperacetazine (Quide) in ambulatory schizophrenic patients--therapeutic efficacy and toxicity.
    Donlon PT; Rada RT
    Dis Nerv Syst; 1974 May; 35(5):231-6. PubMed ID: 17894106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Peculiarities of ECG in patients with phenothiazine-induced cardiomyopathy].
    Volkov VP
    Klin Med (Mosk); 2011; 89(4):27-30. PubMed ID: 21932558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting phenothiazines in schizophrenia.
    Freeman H
    Lancet; 1972 Dec; 2(7789):1245-6. PubMed ID: 4117727
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model.
    Hard ML; Mills RJ; Sadler BM; Wehr AY; Weiden PJ; von Moltke L
    CNS Drugs; 2017 Jul; 31(7):617-624. PubMed ID: 28597226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.